日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis.

用于治疗抗NMDA受体脑炎的单克隆人源化单价抗体阻断疗法

Kanno Atsuo, Kito Takuya, Maeda Masashi, Yamaki Shanni, Amano Yasushi, Shimomura Takuya, Anisimova Margarita, Kanazawa Naomi, Suzuki Koichiro, Razai Amir, Mihara Takuma, Kubo Kaori, Shimada Takeshi, Nakamura Koji, Nomura Naoko, Kondo Yuji, Okimoto Akira, Sugiyama Azusa, Park Deborah, Stein Ivar, Petshow Samuel, Vandendoren Valentin, Bilic Sanela, Kazimi Roghiye, Eastman Vallari, Snipas Scott J, Mitchell Mathew, Maurer Mari, Jefson Marty, Lichter Jay, Yamajuku Daisuke, Shirai Hiroki, Adachi Megumi, Hoeppner Daniel J, Kubo Satoshi, Zito Karen, Iizuka Takahiro, Flynn Peter, Matsumoto Mitsuyuki

Activity-dependent regulation of Cdc42 by Ephexin5 drives synapse growth and stabilization

Ephexin5 对 Cdc42 的活性依赖性调控驱动突触生长和稳定

Petshow, Samuel; Coblentz, Azariah; Hamilton, Andrew M; Sarkar, Dipannita; Anisimova, Margarita; Flores, Juan C; Zito, Karen

d-Serine Inhibits Non-ionotropic NMDA Receptor Signaling

d-丝氨酸抑制非离子型NMDA受体信号传导

Barragan, Eden V; Anisimova, Margarita; Vijayakumar, Vishnu; Coblentz, Azariah; Park, Deborah K; Salaka, Raghava Jagadeesh; Nisan, Atheer F K; Petshow, Samuel; Dore, Kim; Zito, Karen; Gray, John A